The identification of zonulin/preheptaglobin-2 receptor inthe human brain [21], as well aszonulin/preheptaglobin-2 overexpression in gliomas, and its correlation to the degradation of theBBB [22], prompted us to analyze itspresence in glioma C6 CM. The gene discussed is HP; the disease is central nervous system cancer.